FDA tried to discredit whistleblower over drug safety claims

November 24, 2004

The Food and Drug Administration (FDA) tried to discredit one of its own experts after he told a US Senate hearing that the FDA had failed to protect the public over rofecoxib (Vioxx), according to two articles published online by the BMJ today.

Dr David Graham, Associate Director in the FDA's Office of Drug Safety, said that the FDA was "incapable of protecting America against another Vioxx." He also indicated that five other drugs currently on the market may be endangering patients.

Dr Graham led a study that looked at the cardiovascular risks in patients taking rofecoxib (Vioxx). This was to have been published in the Lancet but was pulled at the last minute after Dr Graham had a warning from his supervisor about publication

The FDA issued a statement after the hearing last week, claiming that Dr Graham had failed to adhere to agency protocol when he submitted his data to the Lancet.

Fearing for his job, Dr Graham sought the help of the Government Accountability Project, a public interest group that protects whistleblowers in order to promote governmental and corporate accountability.

But the group received another request from an anonymous whistleblower at the FDA who was being "bullied" by Dr Graham. The caller also said that Dr Graham's study could reflect scientific misconduct. After some investigation, the "anonymous" call was found to come from FDA management, attempting to discredit Dr Graham.

Mr Tom Devine, legal director of the Government Accountability Project said the FDA's attacks on Dr Graham's credibility were implausible.

Something is rotten at the heart of the FDA, adds Dr Kamran Abbasi, acting BMJ Editor. As one of the world's leading drug regulators, the FDA needs to show that its primary role is to protect the public and not to protect industry.

Four of the five companies whose drugs Dr Graham said might be endangering patients, have defended their drugs' safety when used as indicated. One company, Roche, had no comment to make on the allegations.
-end-


BMJ

Related Hearing Articles from Brightsurf:

Two molecular handshakes for hearing
Scientists have mapped and simulated those filaments at the atomic level, a discovery that shed lights on how the inner ear works and that could help researchers learn more about how and why people lose the ability to hear.

Proof-of-concept for a new ultra-low-cost hearing aid for age-related hearing loss
A new ultra-affordable and accessible hearing aid made from open-source electronics could soon be available worldwide, according to a study published September 23, 2020 in the open-access journal PLOS ONE by Soham Sinha from the Georgia Institute of Technology, Georgia, US, and colleagues.

Ultra-low-cost hearing aid could address age-related hearing loss worldwide
Using a device that could be built with a dollar's worth of open-source parts and a 3D-printed case, researchers want to help the hundreds of millions of older people worldwide who can't afford existing hearing aids to address their age-related hearing loss.

A promise to restore hearing
For the first time, researchers have used base editing to restore partial hearing to mice with a recessive mutation in the gene TMC1 that causes complete deafness, the first successful example of genome editing to fix a recessive disease-causing mutation.

Surprising hearing talents in cormorants
The great cormorant has more sensitive hearing under water than in air.

Veterinarians: Dogs, too, can experience hearing loss
Just like humans, dogs are sometimes born with impaired hearing or experience hearing loss as a result of disease, inflammation, aging or exposure to noise.

Older people who use hearing aids still report hearing challenges
A high proportion of older people with hearing aids, especially those with lower incomes, report having trouble hearing and difficulty accessing hearing care services, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

Hearing class
New study finds that the class of neurons responsible for transmitting information from the inner ear to the brain is composed of three molecularly distinct subtypes.

Hearing tests on wild whales
Scientists published the first hearing tests on a wild population of healthy marine mammals.

Genes critical for hearing identified
Fifty-two previously unidentified genes that are critical for hearing have been found by testing over 3,000 mouse genes.

Read More: Hearing News and Hearing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.